Pain Therapeutics Inc. (PTIE)

1.27
0.03 2.42
NASDAQ : Health Technology
Prev Close 1.24
Open 1.25
Day Low/High 1.24 / 1.29
52 Wk Low/High 0.76 / 8.76
Volume 62.23K
Avg Volume 278.10K
Exchange NASDAQ
Shares Outstanding 17.22M
Market Cap 19.97M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

King Pharmaceuticals, Oil Rigs: Hot Trends

King Pharmaceuticals, 'offshore oil rigs,' Internet TV and patch 4.0.1 are the trending topics on Google and Yahoo.

King Pharma Says It Launched Pain Drug Embeda

King Pharma Says It Launched Pain Drug Embeda

King says its pain drug Embeda, designed to be resist abuse attempts, is now available

Ahead Of The Bell: King Pharmaceuticals

Ahead Of The Bell: King Pharmaceuticals

Analysts say FDA approval of King Pharmaceuticals painkiller is positive, expected

Director Buys $6.9M Worth of Jazz Pharma

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

A Pair of Product Updates

Two of our model portfolio pharmaceutical names posted news regarding their respective pipelines. Here's our take.

Deborah Marriott Harrison Sells $3M Worth

Deborah Marriott Harrison Sells $3M Worth

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Funds Sell $4M Worth of Pain Therapeutics

Funds Sell $4M Worth of Pain Therapeutics

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Two Funds Sells $6.3M of Pain Therapeutics

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Health Winners & Losers: Vivus

Health Winners & Losers: Vivus

Amylin is down 20.1%.

Health Winners & Losers: Altus

Shares of the company drop after announcing late-stage trial results that disappoint the Street.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Oculus plunges after announcing plans for a stock offering , while Pain Therapeutics gets an analyst boost.

Feuerstein's Biotech-Stock Mailbag

Feuerstein's Biotech-Stock Mailbag

It's still too early to be a Pain Therapeutics bull.

Study Results Boost Pain Therapeutics

Study Results Boost Pain Therapeutics

Chronic-pain drug Remoxy shows positive results in a phase III trial.

Stockpickr Lists: Chicago Board of Trade Hits High

Stockpickr Lists: Chicago Board of Trade Hits High

An improved offer from the Chicago Mercantile Exchange sent shares of the exchange to new heights.

Wednesday's Small-Cap Winners & Losers

Wednesday's Small-Cap Winners & Losers

TTM Technologies surges on a first-quarter earnings beat.

Thursday's Buybacks: Pain Therapeutics for $20 Million

Here's a list of companies that have recently announced buybacks.

Stockpickr: Check Out These Two Biotechs

Stockpickr: Check Out These Two Biotechs

Analysis from do-it-yourself portfolios offer intriguing stock ideas.

Patterns Lack Bullishness

A correction after the initial flurry of January activity is possible, but wait and see how things unfold.

Selling Pressure Continues

Be suspicious about emerging trends as triple-witching lies just ahead on the calendar.

'RealMoney' Radio Recap: The Mercurial Market

'RealMoney' Radio Recap: The Mercurial Market

Aaron Task, filling in for Cramer, says it's all about how to view the Fed's next move. Also, heavy metal.

Today's Health Winners and Losers

Today's Health Winners and Losers

OraSure plunges after a lower-than-expected 2006 forecast.

Cramer's 'Mad Money' Recap: A Pain-Free Stock Play

Cramer's 'Mad Money' Recap: A Pain-Free Stock Play

Pain Therapeutics could make a killing if it succeeds in developing abuse-resistant opiates.

Health Stocks in Motion

Health Stocks in Motion

Pain Therapeutics tumbles after discontinuing development of an irritable bowel syndrome drug.

Health Stocks in Motion

Health Stocks in Motion

Pain Therapeutics plunges after a trial of its pain drug fails to show statistical significance.

Cramer's 'Mad Money' Recap: Chile Con Economy

Cramer's 'Mad Money' Recap: Chile Con Economy

With a 4% budget surplus, Chile is hot with investment opportunities, says Cramer.